CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen ... (and/or remove certain viruses during man...)

HOME >> MEDICINE >> TECHNOLOGY

CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency

Date:3/11/2009

and/or remove certain viruses during manufacturing. Despite these measures, such products may still potentially transmit disease. There is also the possibility that unknown infectious agents may be present in such products.

The most serious adverse reactions that have been reported in clinical studies or through postmarketing surveillance following RiaSTAP treatment are allergic-anaphylactic reactions and thromboembolic episodes, including myocardial infarction, pulmonary embolism, deep vein thrombosis and arterial thrombosis. The most common adverse reactions that have been reported in clinical studies or through postmarketing surveillance following RiaSTAP treatment are allergic reactions and generalized reactions such as chills, fever, nausea and vomiting.

For more information, visit www.riastap.com.

About CSL Behring

CSL Behring is a global leader in the plasma protein biotherapeutics industry. Passionate about improving the quality of patients' lives, CSL Behring manufactures and markets a range of safe and effective plasma-derived and recombinant products and related services. The company's therapies are used in the treatment of immune deficiency disorders, hemophilia, von Willebrand disease, other bleeding disorders and inherited emphysema. Other products are used for the prevention of hemolytic diseases in the newborn, in cardiac surgery, organ transplantation and in the treatment of burns. The company also operates one of the world's largest plasma collection networks, ZLB Plasma. CSL Behring is a subsidiary of CSL Limited, a biopharmaceutical company with headquarters in Melbourne, Australia. For more information, visit www.cslbehring.com.

    Contact:
    Sheila A. Burke, Director, Communications & Public Relations
    W
'/>"/>
SOURCE  CSL Behring
Copyright©2009 PR Newswire.
All rights reserved 
0

GOOD

Page: 1 2 3 4 
Related medicine technology :

1. Over $10 Million of CSL Behrings Privigen Was Sold in the U.S. During the Third Quarter of 2008
2. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
3. CSL Behring Study in Animal Models Shows Feasibility of Developing a Half-Life Extended Recombinant FVIIa that Retains Biologic Activity
4. CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
5. Childrens Hospital Receives $6.7 Million Grant From Gates Foundation to Study Influenza Vaccine in Pregnant Women in Asia
6. deCODE Receives California Clinical Laboratory License
7. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
8. Phico Therapeutics Receives GBP1 Million Award From the Wellcome Trust to Take Anti-MRSA Nasal Product Through Early Clinical Trials
9. PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications
10. Kiadis Pharma Receives Two Orphan Drug Designations for Reviroc(TM) From the FDA
11. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial

Post Your Comments:

(Date:12/15/2009)... ST. LOUIS, Dec. 15 KV ... 10, 2009, the Company received a written notice (the ... DTD 7/23/99, a stockholder of the Company, requesting that ... fix a record date for stockholder action by written ... to fill a vacant director seat resulting from Ronald ...

(Date:12/15/2009)... what something looks like up close and personal? ASPEX ... Electron Microscope (PSEM), kicked off its "Send Us Your ... be scanned by one of their PSEMs. ... to 5mm and an imaging resolution of 25nm, capable ... ASPEX will not only scan your sample, but will ...

(Date:12/15/2009)... an opportune time to find the best plan at ... 15 Through the end of the year, ... decisions about their health coverage. This is when ... health benefits they will sign up and pay for ... critical part of this decision, says Independent Retail Pharmacist ...

Breaking Medicine Technology:KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 2 KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 3 KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 4 KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 5 KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 6 KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 7 ASPEX Kicks Off Free 'Send Us Your Sample' Microscopy Campaign 2 Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans 2 New Compound Shrinks Skin Cancers 56070 1 New Compound Shrinks Skin Cancers 56070 2 New Compound Shrinks Skin Cancers 56070 3 New Compound Shrinks Skin Cancers 56070 4 YouTube videos yield clues to brain injury symptom 56068 1 YouTube videos yield clues to brain injury symptom 56068 2 NOAA report explains sea level anomaly this summer along the US Atlantic coast 9772 1

[0] KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent [0] ASPEX Kicks Off Free 'Send Us Your Sample' Microscopy Campaign [0] Pharmacist Urges Nebraska Medicare Beneficiaries to Compare Prescription Plans

... Abstract # 2905DENVER, April 20 Scientists ... in Detroit today presented data at the ... Meeting 2009 that represents significant research advancements ... forms of invasive breast cancer.(Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO ...

... display exceeds performance expectations.LIVONIA, Mich., April 20 On Friday, ... surgeons and their medical support team assembled to perform a ... new LifeVision(TM) family of 3D technologies developed by Absolute Imaging, ... the first time in history that a surgeon ...

Other Medicine Technology:Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference 2 Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference 3 Oakwood Surgeons Perform World's First 3D Surgery Without Special Glasses 2 Oakwood Surgeons Perform World's First 3D Surgery Without Special Glasses 3 Oakwood Surgeons Perform World's First 3D Surgery Without Special Glasses 4

Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference Oakwood Surgeons Perform World's First 3D Surgery Without Special Glasses

(Date:12/15/2009)... ,we would have really been in trouble, expert says ... of the pandemic H1N1 swine flu has revealed serious ... health emergencies, a new report says. , The report, ... Robert Wood Johnson Foundation, also finds the dire economy ... "The 2009 H1N1 outbreak is the latest in a ...

(Date:12/15/2009)... Dec. 15 Knowledge ... the pharmaceutical and bio-tech research market with ... Over the past 11 years CMR has ... Consulting Network (PCN®), which now includes 70,000 ... both primary care and hard-to-reach specialties. ...

(Date:12/15/2009)... The new compact LifeSpan TR200 folding treadmill, ... ), was highly praised by treadmill review groups ... The compact TR200 folding treadmill received awards for Best ... $1000. ,, The compact LifeSpan TR200 treadmill is ... spaces. "This category buster is a very compact treadmill ...

(Date:12/15/2009)... service, such as tutoring children, can help older ... to a study led by researchers at the ... functional magnetic resonance imaging (fMRI), the researchers found ... made gains in key brain regions that support ... daily life. The study is the first of ...

(Date:12/15/2009)... Affiliate Program, a new employment opportunity for the unemployed or those ... business opportunities in America today. , ... Orlando, FL ... most successful collection agencies, is spreading holiday cheer and good will ... RPS has created an opportunity for out of work Americans ...

Breaking Medicine News(10 mins):Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 2 Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 3 Health News:Knowledge Networks Expands in Pharma Research With Acquisition of CMR 2 Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2 Health News:For older adults, participating in social service activities can improve brain functions 2 Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 2 Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 3

[0] Serious Gaps Revealed in U.S. Response to Health Emergencies [1] Knowledge Networks Expands in Pharma Research With Acquisition of CMR [0] Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill [1] For older adults, participating in social service activities can improve brain functions [0] RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away

... N.Y., Feb. 12 The Lisa Beth,Gerstman Foundation (LBGF) ... of sending physically disabled children in the,Northeast United States ... Foundation send physically disabled children to,summer camp at no ... the New,York Metro area. Foundation camp programs are in ...

... The recent influenza,outbreaks across the country, resulting in ... stark reminder that the influenza virus is a serious ... that influenza hospitalizes more than 20,000 children,younger than 5 ... -- and causes,approximately 100 deaths. These statistics are particularly ...

... soft sounds in response to the sounds that travel ... doctors test newborns hearing. A deaf ear doesnt produce ... of Michigan and Oregon Health and Science University shows ... dont leave the ear the same way they entered. ...

... ... ... FY 2007:, euro 6,961 million ... 15.7% in U.S. dollars(2)), BRIDGEWATER, N.J., Feb. 12 ...

... a Face: Notes on a Life in Medicine, by Maria Siemionow, ... ... you determine the value of a,face? Imagine, for a moment, being unable to ... the burden a disfigured,person carries," writes Dr. Maria Siemionow, section head of plastic,surgery ...

... and the School of Medicine have devised a micro-scale tool - ... complexities of the brain. The system should help scientists better understand ... nervous system. , A report on the work appears as ... journal Lab on a Chip. , The chip weve developed ...

Lisa Beth Gerstman Foundation Awarded CVS/pharmacy Community Grant Childhood Influenza Immunization Coalition Responds to Recent Influenza Outbreaks New findings contradict a prevailing belief about the inner ear Sanofi-aventis Announces 2007 Earnings Ahead of Guidance Sharp Rise in Proposed Dividend Cleveland Clinic Press Releases Book About a Surgeon's Mission to Perform the World's First Full Face Transplant 'Lab on a chip' mimics brain chemistry

... chairs with concave seats and large ... options like seats, backrests, armrests, and ... BE Series for top performance in ... education, laboratory, clean room, static control, ...

... with concave seats and large backrests ... like seats, backrests, armrests, and casters ... Series for top performance in a ... laboratory, clean room, static control, health ...

... with concave seats and large backrests with ... backrests, armrests, and casters and glides. • ... in a variety of environments including: industry, ... care and office. • With reinforced nylon ...

... chairs with concave seats and large ... options like seats, backrests, armrests, and ... BE Series for top performance in ... education, laboratory, clean room, static control, ...

Medicine Products:

BEP/1Q-PAL-ERB - Polished Aluminum Base - Model 1Q43-PAL-ERB BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q66-CAB-ERB BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q53-R-CAB-ERB BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q72-CAB-ERB

CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen ...(and/or remove certain viruses during man...),Health